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     Absztrakt 
   A telemedicina szárnyán, egy vállalkozó orvos szemszögéből részt vehetünk egy Üzleti 
Angyal befektésben és exitben, megnézhetjük az orvosi társadalom szempontjait, majd a 
piaci kudarcot egy újabb VC befeketés menti meg, létrejön a kormányzati szabályozás, és 
intézményesül az innováció. A tanulmány jogi, közgazdasági, egészségügyi, adatvédelmi 
témákat érint, azokat összefüggéseiben tárgyalja, felvetítve egy elképzelt jövőbeli 
mesterséges intelligencia által támogatott technológiai és egészségügyi - társadalmi 
jövőképet.  
   Kulcsszavak: Egészségügyi jog, Mesterséges Intelligencia, Telemedicina, adatvédelem 
   Diszciplinák: orvostudomány, jogtudomány, közgazdaságtudomány  
 
   Abstract 
   AI VÍZIÓ #1  
   – VISZLÁT BETEGEKNEK SZÓLÓ ASZIMMETRIKUS INFORMÁCIÓK?! 
   Having a ride in a future AI investment project, you can see a telemedicine start up 
from a physician point of view, you will see a Business Angel investment and exit, also a 
market failure cured by a VC investment, a government ruling and finally the vision of 
innovation. The article is about legal, economic, medical and data privacy issues and their 
close consequences in a future AI innovation.  
   Keywords: medical law, AI, telemedicine, Healthcare, data privacy 
   Disciplines: medicine, law and economy  
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   Patients, Physicians, Social Funds, VCs 
and Regulatory were all happy, though 
they had not had any trust in using AI at 
the beginning. Having a ride in a future AI 
investment project, you can see a tele-
medicine start up from a physician point of 
view, you will see a Business Angel 
investment and exit, also a market failure 
cured by a VC investment, a government 
ruling and finally the vision of innovation. 
The article is about legal, economic, 
medical and data privacy issues and their 




   Asymmetric information 
   in Healthcare 
   Once upon a time, a Medical Resident 
recognized that the leaflets at the reception 
desks in his/her hospital were not up to 
date. The receptionists were not always 
well informed about the changes, and 
sometimes the quality of information the 
Patient received were depending on the 
personal current ability to answer. While 
the Resident was responsible to give 
proper information to Patients of his/her 
medical care to have the consent for the 
treatment, Residents realized that so much 
information was about non - medical 
questions though he/she was not 
experienced to answer them or was not up 
to dated.  Why not to digitalize it and 
automatize the whole info process?  – he 
asked.  
   It was obvious that the informed 
consent of any medical treatment could 
not rely on “smart computers”. Patients’ 
point of view he/she would not 
understand fully his/her diagnosis, the 
available care and therapy, the costs and 
efficiency, the costs and efficacy. So, 
he/she would rely on his doctor’s (as an 
agent) opinion and based on this 
suggestion he/she (as Mandator) would 
give the consent on the treatment. If an 
Agent made the decision, and he/she was 
part of the service, this would be the 
situation when supplier induced demand. 
Monopoly situation which could be 
balanced by medical guidelines and 
protocols or make patients financially 
interested to get as much as information 
available by a mechanism of co-insurance, 
co-payment, deductibles (Gulácsi, 2005). 
The lack of proper information to give 
informed consent let lawyers easy to win in 
front of a court to claim for compensation 
on behalf of patients instead of demand 
compensation for medical malpractice. 
This was the reason why hospitals would 
not approve to give information indirectly 
via outside telemedicine solutions, since 
the hospital would be responsible in such 
court actions. To avoid such cases, 
hospitals had their own policies and 
protocols to inform the Patient as their 
local specialties. So, the info asymmetry 
still stood against Patient which could be 
balanced by legal or financial mechanisms. 
 
   Startup 
   The young Medical Resident met IT 
fellows and lawyers to find out how to save 







Patients more info. The IT solution 
collected information from hospitals and 
could satisfy Patients (like consumers) to 
manage an always available, a researchable, 
a printable, and an up-to-date webpage. 
None of the hospitals wanted to be partner 
since the legal difficulties of giving proper 
information was legal risk for them, but a 
Business Angel found the market niche, 
lots of computable data and lots of 
customers always meant big profit. The 
investment process was not easy, black 
box affect, regulatory issues, the negative 
and defensive approach of hospitals made 
the business plan uncertainty, and it was 
extremely hard to draft a joint venture 
agreement. The Busines Angel was 
engaged to make investments which had 
social impact, in this way he/she could 
agree in such a risky term sheet. 
 
 
   Market proof 
   As a result of the investment, the 
“medical yellow pages” (hereinafter 
Teledoc) was launched and set up a 
common platform for the Hospitals and 
Patients. Teledoc was free for everyone, 
including any service providers. First, they 
collected useful but non-medical in-
formation, Teledoc took over the 
management of useful information and it 
was a public interest. Teledoc became a 
trusted source of information, it was 
popular among Patients. General medical 
information like how to get prepared for 
blood collection, when and what to eat or 
drink before and after it. Teledoc system 
developed itself like deep learning 
mechanism, the Patient asked, and the 
Physicians answered. In this way Teledoc 
system developed a huge database case by 
case, which was clean, systematic, and 
professional. Also, each hospital features 
could also be handled in accordance with 
local protocols, the Patient could choose 
how to get prepared for treatment 
according to his/her place of residence. 
For example, what is expected in the local 
hospital in case of maternity, what 
“hospital package” should be prepared, 
what was allowed to take to hospitals and 
what was not, what baby clothes and 
things could be taken, when and who 
could visit the maternity department. The 
development of telemedicine was the next 
step to become popular, and other 
policlinic and primary care providers 
wanted to join. They used a booking 
system, which was available free of charge 
to all participants. It was only one step to 
contact the doctor directly via the 
Teledoc’s infrastructure, either over the 
web or even over the phone, to avoid 
tumult and waiting in the corridors. The 
revenue corners of Teledoc also developed 
as planned, and pharmaceutical 
companies, private providers, lifestyle, and 
wellness companies immediately joined 
Teledoc, which now has thousands of 
registered users and dozens of institutions. 
With profits from sponsorship fees and 
other advertising, the 4-person manage-
ment was able to buy out the initial 
investor, who were able to exit his/her 







   Market failure 
   Telemedicine companies such as 
Teledoc became popular, and the control 
authorities received more complaints 
about such companies, and also the 
majority of the health society was not 
happy either. While some healthcare 
professionals noticed that they were able 
to spend more time dealing with the 
Patients, they already arrived well 
informed for the examinations. Yet most 
doctors felt tired and frustrated by the way 
Patients handled the information they had 
received via Teledoc and other Tele-
medicine Companies, and doctors’ 
response to questions generated three 
other questions. Some Patients even asked 
their doctors to have more available tests 
or other treatments. It remained the 
responsibility of service provider’s to 
obtain the Patient's consent for the 
treatment, and unregulated telemedicine 
providers had confused the previous 
established communication habits of 
doctors, and thus the principle of gradual 
information was not fulfilled. At the same 
time, the expansion of Teledoc slowed 
down, fixed costs had increased, sponsors 
had not only supported Teledoc, so the 
source of revenue were distributed among 
other Telemedicine companies. 
 
 
   Government intervention 
   Facing of many complaints, the control 
authorities carried out targeted and sub-
ject-matter investigations. Based on the 
authority findings, the government 
commenced to create additional strict 
professional and substantial conditions for 
Teledoc and similar companies. For 
example, full-time employment of an 
adequate staff, ongoing reporting and 
internal regulatory obligations, high in-
formation security requirements, stand-
ards for consumer protection and service 
levels. The fulfilment of increased per-
sonnel and tangible requirements meant 
increased expenditures in addition to 




   Co-investment 
   After the successful Business Angel 
investment and exit, the management of 
Teledoc decided to invite a co-investor to 
make the company profitable again. The 
investor, who came as a regional venture 
capital fund, started development with 
professional portfolio managers, extensive 
business relationships and a regional 
approach. After extensive market research 
and analysis, it revealed that the future lies 
in the data economy. In Healthcare this 
meant, that along with "bedside" as well as 
"webside" should have been a channel for 
health information and communication. 
Information of Patients were managed in a 
health administration system and database, 
which was introduced in the meantime by 
the government, which recorded the 
Patient's medical history and treatment in 
the System. In addition, individual 
measuring devices could help a lot– 







hypochondriac measured his/her heart 
rate and blood pressure in every 4 hours a 
day and noted the measurements in a 
school booklet so that he/she could show 
his/her Doctor what his/her illness was. 
Why do you need hypochondria to detect 
this these days? You have got the 
smartwatch, the fitness watch, you just 
must be able to get the data out of it. Not 
to mention what a goldmine this could be 
for a pharmaceutical company in clinical 
research. Recognizing the latter, a lot of 
smart devices became available for people 
who registered for free. Which was not 
free of charge, since the user paid for it 
with his/her data, but Patients had a 




   Legal & Social obstacles 
   Investments were converted to data 
assets, huge regional and global databases 
were created, the computing capacity to 
manage them were developed, and they 
needed to be managed. The legal obstacle 
to manage data was primarily a rethinking 
of data privacy rules. From a data 
protection point of view, specific health 
rules have been developed which, on 
grounds of health interest, as a stand-alone 
legal basis, had allowed the controller to 
use the health data, which were special 
(sensitive) data, in large numbers, by 
means of machine processing, ano-
nymously for research purposes, or to be 
transferred, recorded, evaluated, and 
extracted, even online, in a non-
anonymous manner based on the same 
legal basis.  
   The other obstacle against innovative 
data management tools was because 
Doctors were obviously unwilling to use 
data, they did not measure at first. It 
remained Doctors’ responsibility to make 
a diagnosis, and according to their studies, 
they had to carry out the tests based on 
measurements under credible and labo-
ratory conditions. Therefore, the Govern-
ment required in its mandatory training 
system to introduce new results related to 
the data economy. Doctors, based on their 
own experience, realized that these 
unauthenticated devices could raise 
suspicions, even if they had not provided 
certainty. Thus, while maintaining liability 
rules, modern tools and methods have 
been integrated into healthcare, a secure 
and responsible data industry was 
established in healthcare, which picked up, 
managed, processed, operated, protected, 
developed the hardware and software 
environment, cleaned, analyzed, and 
researched data, which required enormous 
computing capacity, automation, and the 
development of new kinds of cognition 
and coding innovation. The deep learning 
machine, a special type of artificial 
intelligence deployed in several fields, was 
the right tool for this. 
 
   Speed up of implementing 
   innovative technologies 
   Accelerated events happened during an 
unfortunate pandemic. The Doctor's 







use of modern means of communication. 
Due to the possible and fragmentation of 
individual clinic and hospital booking 
systems, it was no longer able to avoid 
mass waiting rooms. Therefore, there was 
a need at government level for the use of 
modern tools and institutional tele-
medicine. It was not possible to build this 
immediately, so governments had two 
options: either involve the Teledoc and 
Telemedicine services, web doctor 
applications, management systems avail-
able on the market, call center applications. 
Second option was that government 
bought such companies and, by regulation, 




   AI changed  
   the asymmetric information flow 
   As the pandemic had passed, the need of 
immediate digitization made the medical 
society realized that innovative tools were 
not against them, and successfully sup-
ported their operation. Teledoc became a 
healthcare customer contact center, using 
the most advanced artificial intelligence 
opportunities, and was on the market as a 
regional provider. The revenues included 
social security funding, such as care 
management selected through public 
procurement and outsourced in this way, 
whose policies, professional protocols and 
measurement, key indicators were 
developed jointly by the service providers 
with the Social Insurance Funds. Care 
management via the Patient pathway 
calculated on the Patient's initiative and 
input a personalized assessment of when 
testing, intervention and treatment are 
expected, taking account the waiting lists 
available from the hospital databases. The 
Patient could then decide whether to 
follow the recommended path or follow 
the path of his doctor, who may also 
initiate the optimal determination of the 
Patient’s path in the system.  
   The efficiency and effectivity of the 
medical service was also analyzed by using 
artificial intelligence system on the social 
security side. In this way the Health 
Administration, Social Security and 
Supervising Authority were able to control 
spending and efficiency, so that the service 
providers could gain bonus revenues 
rather than performance limitations in case 
over performance of key indicators.  
   Decisions of financing are still not made 
by Patients, often not by doctors, but by 
providers and the Funds. However, the 
monopoly of supply and information 
asymmetry can be counterbalanced using 
such innovations by processing accurate 
and up-to-date information obtained 
during Patient route management and 
follow-up. The information thus 
processed and the Patient’s personal 
feedback on the changed or restored 
quality of lifestyle (health stock – Gulacsi, 
2005) the treatment itself, the quality of the 
personal and material conditions, the style 
in which the patient was informed, the 
Doctor- Patient communication, all 









   AI Future – Utopia? 
   Innovations of smart computers and 
data technology improvements changed 
the law, key players of the Health Market 
could have been the engine of 
development, the question was just the 
timing.  
   Smart computers & Law: Computing 
capacities were available to exploit the 
clean and uniform databases. After 
legislation established the special legal 
basis of controlling and managing medical 
data, that could be researched ano-
nymously, the use of artificial intelligence 
(AI) was expanding. The liability for 
causing damages was still on the Service 
Provider’s behalf, who was responsible for 
approving smart computer’s operation. 
The company which produced the 
hardware and software background of 
smart computers would be the final to pay 
for the compensations in case of damages. 
The smart computing companies had to 
had special insurance for this risk to cover 
and had to paid contribution to a special 
Fund. The special Fund Managers would 
be market supervisors as well, and they 
would create standards and ethical codes 
and would watch the market by using 
independent supervisors. 
   Social Funds and Patients: Using of 
innovative Healthtech solutions increased 
the costs of Funds first. At the same time, 
Patients were much keen on buying 
innovative services even if they had to pay 
extra fee for it, the Patient’s Trust in AI 
sprang up, so the medical innovations and 
investments improved year on year, the 
rapid increase and market utilization of the 
technology gained further innovations, 
and access for Patients to medical services 
improved. As a result of increased access 
to medical services, the Funds had more 
Patients, and they gained higher income.  
   Medical Staff: The fear of health workers 
of losing their jobs by using smart 
computers and machines did not prove the 
truth. New jobs were created for the 
operation, programming, development 
and testing of smart computers, or 
machines managed by AI solutions. To 
teach a computer to be smart needed huge 
number of qualified professionals and new 
job functions, new professions had to be 
educated in Schools as well.  
   Venture Capital investors (‘VCs’): Clinical 
trials to find subjects never had been easy, 
but after startups tested AI on huge 
amount of anonymous data to learn from, 
the medical services and products were 
easier and faster, and even cheaper got to 
regulatory admissions. VC investments 
could afford to take high risks to be guinea 
pigs in the use of AI in HealthTech 
Industry and had successful exits. After the 
market proof of AI services in Health 
Industry, the risk of investing HealthTech 
was reduced, so everyone wanted to invest 
into the “Goldmine”. 
 
 
   Predictions and possible  
   future products & services 
   Radiology: In the case of mammogram 







opinions were required at the time of 
diagnosis. In this resource intensive area, 
with the introduction of the AI 
application, the problem of missing 
medical human resources was almost 
solved. After many years of clinical tests, 
one of the two mandatory medical 
opinions would be replaced by machine 
processing and pre-screening, the AI-
based application achieved and surpassed 
the processing capacity of a human 
professional through thousands of 
analyses. Although it was still a doctor who 
made the final diagnosis, in the field of 
imaging diagnostics, the possibility of 
spreading AI would have been opened 
(Net1).   
   Screening test: In shopping centers, the 
former photo shop booths for ID card 
photos were replaced by AI rapid screen-
ing stations. The patient placed his/her 
palm in the booth on a diagnostic surface 
through which he/she examined his/her 
pulse, heart rate, skin, hair, and nail 
condition, performed an automatic voice 
sample analysis, asked a few questions 
about the patient's complaint or condition, 
answered questions, and gave quick 
suggestions as to which general practi-
tioner or specialist to visit with his/her 
complaint. In return for the charges, the 
Patient received medical data and suggest-
ions by e-mail or phone, giving him/her 
the available office contact details of 
his/her doctor (Gáti, 2020).   
   Surgery: From remote locations, via a 5G 
data transmission channel, minor surgical 
procedures can be performed using ro-
botic arms, which AI continuously 
analyses and assists, for example by 
providing hand tremor insurance to the 
doctor operating through the robotic arms. 
(see: a 'Banana Operation'  in Net2). 
   Pharma: Companies and authorities, 
especially Patients, no longer had to fear 
falsification of medicines after using AI 
and blockchain technology. Blockchain 
ensures the control of safe drug pathway 
data, and AI evaluated of large amounts of 
data. Pharma companies and also Autho-
rities, Social Funds could track un-
necessary prescriptions and purchases, but 
also they could ensure that counterfeit 
medicines do not reach the market. 
   Clinical research: In many cases, AI 
accelerates research phases or even skips 
individual steps in the field of individual 
diseases, the physiological effect of the 
molecular compositions in the test tube is 
tested by computer simulation (Callaway, 
2020).   
   Inpatient care: Inpatient care had also 
undergone a major change, the charts and 
Patient documentation were no longer 
kept manually. The nurse recorded the 
Patient's condition in a voice system, so 
that it was processed immediately. The 
following shift staff saw every single 
medical data that had been recorded. 
General disinfection of rooms, collection 
of laundry and garbage was carried out by 
self-driven robots. AI based system 
calculated individually the food pro-
portions, based on medical and dietetic 
recommendations, depending on personal 







movement, and took care of procurement 
orders and logistics. Meals were also 
distributed by self-propelled robots and 
also logged the leftovers when collecting 
the dishes and generated a report to the 
Patient's file (Ráski, 2020, Meskó and 
Radó, 2020).   
   Dentistry: At the dentist, a 3D technology 
device was used to map the Patient's 
mouth, teeth and previous panoramic X-
rays, which allowed the dental technician 
to customize the new tooth or dentures 
using an artificial intelligence application. 
This design was presented to the Patient, 
who could choose additional shapes, 
patterns, color codes based on dental plans 
(CAM) made from his/her own mouth. 
The approved tooth test (patient’s 
consent) would be sent online, which 
would also be printed by a third provider's 
artificial intelligence 3D printer (CAD) and 
delivered to the dentist.  If oral surgery was 
required or an implant was implanted in 
the mouth, the oral surgeon was assisted 
by artificial intelligence on a 3D projector 
to show how deep he could drill, where to 
drill exactly when the patient moved in, 
and where not to drill, where nerves ran 
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